ArticleFrontiers in cell and developmental biology2025

Correction: PARP1 inhibitor combined with oxaliplatin efficiently suppresses oxaliplatin resistance in gastric cancer-derived organoids via homologous recombination and the base excision repair pathway.

Huafu Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.